![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 33, 25202-25206, August 18, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, March 16, 2000, and in revised form, May 17, 2000
The biological activity of gliotoxin is dependent
on the presence of a strained disulfide bond that can react with
accessible cysteine residues on proteins. Rabbit muscle creatine kinase
contains 4 cysteines per 42-kDa subunit and is active in solution as a dimer. Only Cys-282 has been identified as essential for activity. Modification of this residue results in loss of activity of the enzyme.
Treatment of creatine kinase with gliotoxin resulted in a
time-dependent loss of activity abrogated in the presence
of reducing agents. Activity was restored when the inactivated enzyme was treated with reducing agents. Inactivation of creatine kinase by
gliotoxin was accompanied by the formation of a 37-kDa form of the
enzyme. This oxidized form of creatine kinase was rapidly reconverted
to the 42-kDa species by the addition of reducing agents concomitant
with restoration of activity. A 1:1 mixture of the oxidized and reduced
monomer forms of creatine kinase as shown on polyacrylamide gel
electrophoresis was equivalent to the activity of the fully
reduced form of the enzyme consistent with only one reduced monomer of
the dimer necessary for complete activity. Conversion of the second
monomeric species of the dimer to the oxidized form by gliotoxin
correlated with loss of activity. Our data are consistent with
gliotoxin inducing the formation of an internal disulfide bond in
creatine kinase by initially binding and possibly activating a cysteine
residue on the protein, followed by reaction with a second neighboring
thiol. The recently published crystal structure of creatine kinase
suggests the disulfide is formed between Cys-282 and Cys-73.
Gliotoxin is a member of the epipolythiodioxopiperazine
(ETP)1 class of biologically
active fungal metabolites that is characterized by the presence of a
bridged disulfide ring that is essential for activity (1, 2). The ETP
toxins are produced by a number of fungi including
Aspergillus fumigatus and have been shown to rapidly
accumulate in cells (3). This is consistent with the perceived role of
ETP toxins as fungal chemical defense agents. ETP toxins may contribute
to the etiology of animal and human fungal diseases (4, 5); they are
known to be selectively toxic to immune cells and to induce apoptosis
(6) although the cellular target(s) have not been defined. Gliotoxin
has been shown to inhibit the activity of alcohol dehydrogenase (7), reverse transcriptase (8), farnesyltransferase (9), and the
transcription factor NF Creatine kinase is a ubiquitous enzyme that catalyzes the reversible
formation of ATP from creatine phosphate and ADP (11). Creatine kinase
has been shown to be coupled to the action of ATP-dependent
membrane ion pumps functioning in the rapid regeneration of ATP from
ADP (12, 13). Mitochondrial creatine kinase may form a component of the
mitochondrial permeability pore (14). Inhibitors of creatine kinase
have been shown to display activity against a number of tumor cell
lines (15). Rabbit muscle creatine kinase is believed to function as a
non-covalently bound dimer of two identical 42-kDa monomers (16).
Because creatine kinase is sensitive to inactivation by reactive oxygen
species and to thiol-specific agents, we examined the effect of
gliotoxin on creatine kinase activity to gain information on
intracellular targets for ETP toxins. In this study, we have shown the
novel conversion of creatine kinase to a 37-kDa oxidized form
consistent with intracellular disulfide formation and consequent loss
of activity. The active 42-kDa native protein was regenerated on treatment with reducing agents. In addition, we propose that a single
functioning reduced monomer in the creatine kinase dimer is sufficient
for full activity whereas the second monomeric component in the
oxidized form does not affect overall activity. Formation of the doubly
oxidized dimer results in complete loss of activity. The intramolecular
disulfide bond is most probably formed between the essential Cys-282
and Cys-73, which are physically in close proximity (17).
Gliotoxin, dithiothreitol, and glutathione were purchased from
Sigma. Pepsin from porcine gastric mucosa was obtained from Roche Diagnostics. Radiolabeled gliotoxin was prepared and
purified using Penicillium terlikowskii fed with
35S-labeled inorganic sulfate (Amersham Pharmacia Biotech)
as described previously (3). Rabbit muscle creatine kinase was
purchased from Sigma and Roche Molecular Biochemicals and used without
further purification. The kinase displayed a single major band on
SDS-polyacrylamide gel electrophoresis of 42 kDa in the presence
of dithiothreitol. A single contaminant that was identified as
phosphoglycerate mutase was found in the Sigma sample but was present
at less than 10% of the total protein.
Activity was measured using either the enzyme-coupled method (18) or
the thymol blue assay (19) typically in the absence of reducing agents
with a Carey UV-visible spectrophotometer. Both assays gave comparable
results. Creatine kinase at 1 mg/ml (25 µM based on the
monomer of 42 kDa) was incubated in NaOH/glycine buffer, pH 9, at
37 oC in a total volume of 1 ml for different time
intervals with gliotoxin. A 5-µl aliquot was removed to assess enzyme
activity. In some experiments, reducing agents were added to the
reaction mixture either at zero time or after complete inactivation of the enzyme. Samples (30 µl) were also taken for non-reducing
SDS-polyacrylamide gel electrophoresis, which was carried out using
published procedures in the absence of reducing agent (20). Bands were
visualized with Coomassie Blue. Autoradiography was carried out on
dried gels using Kodak Biomax MR x-ray film with enhancing screens.
Creatine kinase treated with 35S-labeled gliotoxin (100 µM) for 6 h was washed through a Centriprep-10
filter to remove unbound gliotoxin and digested with pepsin at 1% w/w
for 3 h at 37 oC in 10% formic acid. Peptides were
purified by two-dimensional chromatography using a thin layer
electrophoresis system (Hunter). The first dimension (electrophoresis
at 1 kV and 45 mA for 40 min) used 5% butyl alcohol, 2.5% acetic
acid, 2.5% pyridine, and 90% water, pH 4.7, and the second dimension
(chromatography over 5-6 h) used 39% butyl alcohol, 30% pyridine,
6% acetic acid, and 25% water as the mobile phase. The plate was
air-dried, and labeled peptides were visualized by autoradiography. The
labeled spots on the cellulose were placed in an Eppendorf tube with
100 µl of distilled water and polyvinylidene difluoride membrane and were incubated overnight with complete transfer to the membrane. Sequencing was then carried out as described previously (6).
The stoichiometry of binding of gliotoxin to creatine kinase was
determined by first generating a standard curve using graded concentrations of gliotoxin at known specific activity that were run on
polyacrylamide gels, dried, and exposed to film, and the bands were
quantified using an enhanced laser densitometer (Ultrascan XL). A known
mass of [35S]gliotoxin-labeled creatine kinase was also
run in gels and similarly quantified, thus enabling the mass of
gliotoxin associated with a known mass of protein to be calculated.
Gels were exposed to allow for only those signals that fell in the
linear portion of the standard curve to avoid saturation effects. Prior
to drying and autoradiography, gels were also lightly stained with
Coomassie Blue to determine the ratio of the 42-kDa (reduced) to 37-kDa (oxidized) forms of the enzyme.
Gliotoxin Inactivates Creatine Kinase in a
Time-dependent Manner--
Incubation of creatine kinase
with gliotoxin resulted in a concentration- and
time-dependent loss of activity (Fig.
1). Greater than 80% inactivation
occurred by 6 h with 100 µM toxin. Gliotoxin at 1 and 10 µM had little effect on activity whereas the
effect of 50 µM toxin was equivalent to 100 µM toxin (data not shown). We detected little or no
inactivation in the first 90-120 min of incubation of creatine kinase
with gliotoxin at 100 µM. The profile of inactivation is
consistent with a time-dependent covalent interaction of
gliotoxin with creatine kinase.
The Inhibition Is Abrogated by Reducing Agents Both Pre- and
Postaddition--
Creatine kinase activity at 6 h in the presence
of 50 µM gliotoxin was 25 ± 1.3% of control. In
the continuous presence of 1 mM dithiothreitol or
glutathione and gliotoxin, kinase activity was 93 ± 3 and
73 ± 13%, respectively. A trivial explanation for the protection
seen in pretreatment with reducing agents is that the gliotoxin is now
in the reduced form at time 0 and cannot easily form mixed disulfides
with cysteine residues in the enzyme. More significant is the
restoration of activity by dithiothreitol or glutathione after
inactivation. In a separate experiment, 50 µM gliotoxin
resulted in 19.5 ± 1% of the control activity at 6 h.
Addition of either 1 mM dithiothreitol or glutathione at the 6-h point and re-assay 1 h later resulted in restoration of activity to 73.5 ± 1 and 56.2 ± 3% of the control,
respectively. These results are consistent with inactivation caused by
covalent modification of protein thiol(s) by gliotoxin and reversed by reduction of a newly formed S-S bond. The addition of reducing agents
to ETP toxins has been shown to produce reactive oxygen species by
inducing redox cycling of the dithiol to the disulfide form of the
toxin (21) although this is not observed with creatine kinase.
Gliotoxin Induces the Formation of Oxidized Creatine
Kinase--
Preliminary examination of native creatine kinase on
polyacrylamide gels often revealed a second band of an apparent mass of
37 kDa that was present in varying amounts (Fig.
2A). This band was most
apparent using longer and higher resolution gels in the absence of
reducing agents. Microsequencing of this band showed this to be
identical with native creatine kinase (data not shown). Reducing agents
diminished or completely eliminated this band and correspondingly
increased the 42-kDa band (Fig. 2A, lane 2)
implying that the 37-kDa band was an oxidized form of creatine kinase.
To prepare the reduced form free from the 37-kDa form, creatine kinase
was treated with 500 µM dithiothreitol and then
exhaustively dialyzed to remove potentially interfering dithiothreitol.
On some occasions, significant amounts of up to 50% of the 37-kDa
species were formed after prolonged dialysis as shown in Fig.
2B, lane 1. The activity of the dialyzed sample when compared with creatine kinase stored in 500 µM
dithiothreitol (Fig. 2B, lane 2) was
unaffected.
In a separate experiment we determined that the presence of 100 µM gliotoxin resulted in the rapid formation of this new
band at the expense of the 42-kDa band (Fig.
3). Almost complete conversion occurs by
6 h concomitant with loss of greater than 80% of the enzyme
activity. Fig. 3 shows the biphasic production of the 37-kDa oxidized
form. Complete conversion to 50% of the oxidized 37-kDa form of
creatine kinase occurs within minutes with a slower complete conversion
over 6 h. Addition of 1 mM dithiothreitol resulted in
conversion to the 42-kDa form (Fig. 4)
with the restoration of enzymic activity. Gliotoxin at 10 µM, which has a negligible effect on enzyme activity
(data not shown), also resulted in significant conversion to the
oxidized form. As shown below, this new band cannot be attributed
simply to the addition of molecule(s) of gliotoxin to creatine
kinase.
Loss in Activity Does Not Correlate with Stoichiometric Formation
of the Oxidized Form--
We consistently observed that the oxidized
form of creatine kinase is formed within minutes of treatment with
gliotoxin (Fig. 3) and that significant amounts of the 37-kDa form were
produced with no loss in activity. We measured both the relative
proportion of the 37-kDa band and the activity of the enzyme in the
same experiment. Fig. 5 shows the
relationship between the amount of the 37-kDa form of creatine kinase
and activity. There was no loss of activity until 50% of the protein
had been converted to the 37-kDa form. The data in Fig. 5 are
consistent with our proposal that it is the oxidation of the second
monomer of the creatine kinase dimer that correlates with loss of
activity. The solid lines in Fig. 5 were constructed as
follows. All points corresponding to a proportion of
The data are consistent with initial oxidation of one monomer in the
dimer (with no loss in total activity) followed by oxidation of the
second monomer, which then results in loss of activity. The
dotted line in Fig. 5 is the theoretical line for this
latter model shown in Scheme 1.
Stoichiometry of Gliotoxin Binding to Creatine
Kinase--
Autoradiography of polyacrylamide gels of creatine kinase
treated with 35S-labeled gliotoxin clearly showed that both
the 42- and 37-kDa forms could be covalently labeled (data not shown).
A conventional approach of estimating the number of moles of toxin
bound per mol of protein would give only an average stoichiometry and
would therefore contain no information on the relative binding to the two forms. We used the alternative method described under "Materials and Methods" to determine stoichiometry. Table
I shows the result of such an analysis.
At 5 min, there was an almost exact 1:1 mixture of reduced/oxidized
monomers of creatine kinase with only a fraction of either form
labeled. This indicates that the conversion of reduced to oxidized
creatine kinase can occur without any permanent covalent binding of the
toxin to the monomer. By 3 h, there was 1 gliotoxin associated
with the 37-kDa form and an average of 1.5 gliotoxin molecules
associated with the 42-kDa form. At 4.5 h, there was 68%
conversion with again only 1 mol of gliotoxin associated with the
37-kDa form. The remaining 32% of the 42-kDa form was associated with
more than 3 mol of gliotoxin.
Treatment with 10 µM gliotoxin, which results in a
significant conversion of reduced to oxidized monomer of creatine
kinase, showed less than 8% binding to creatine kinase even at 6 h (data not shown). Formation of the 37-kDa species was not simply due to the effect of increased covalent binding to gliotoxin. Neither the
covalently modified reduced or oxidized form was altered in mobility
relative to unmodified protein at 6 h.
Identification of Cysteine Residues Covalently Modified by
Gliotoxin--
Pepsin in formic acid was used for digests to minimize
scrambling of the radiolabel. A number of radiolabeled peptides were detected in digests of creatine kinase labeled with
[35S]gliotoxin. The labeled peptide fragments that were
isolated showed significant labeling of only Cys-253 and Cys-282. No
peptides corresponding to Cys-73 and only trace amounts corresponding
to Cys-145 were detected.
A typical experiment revealed four radiolabeled spots with
two-dimensional chromatography. Of these, sequencing of two showed peptide residues consistent with binding to only Cys-253
(Arg-Arg-Phe-Cys253-Val-Gly). Sequencing of the other two
labeled spots showed peptide residues from Cys-253 and in lesser
amounts Cys-282 (Val-Leu-Thr-Cys282-Pro-Ser-Asn-Leu). These
results establish binding to Cys-253 at 6 h and possibly some
lesser binding to Cys-282.
The reactive cysteine in creatine kinase has been shown to be
exclusively Cys-282 (22, 23) whereas the other cysteine residues
(Cys-253, Cys-145, and Cys-73) are only accessible when the enzyme is
denatured. Only two thiol groups per dimer are accessible to
p-hydroxymercuribenzoic acid during early denaturation, and these have been shown to be the two Cys-282 residues on each monomer (23). At SDS/protein ratios exceeding 200, Cys-145 and Cys-253 become
accessible. Cys-73 cannot be modified by
p-hydroxymercuribenzoic acid even after complete
denaturation by SDS (23). Cys-253 can become exposed under pressure
(24). Cys-145 is positioned near the monomer/monomer interface (17) and
may become exposed upon dimer dissociation.
Rabbit muscle creatine kinase forms a dimer in solution (25), and it is
proposed that this is the active form (26) although there is evidence
that the monomer can be active (27, 28). A large body of evidence has
demonstrated differential activity of the two Cys-282 residues on each
monomer of the dimer. In the presence of Mg2+, ADP,
creatine, and nitrate, which together form a "transition state
analogue," the reactive thiol groups react at significantly different rates (29). A detailed kinetic study using
5,5'-dithiobis(2-nitrobenzoic acid) and iodoacetic acid confirmed the
biphasic nature of the reaction with Cys-282 (30). Some modifying
groups such as S-cyanide may initially bind to essential
thiols and subsequently migrate or is lost, thus restoring
enzymatic activity (31). It has been shown that regenerated creatine
kinase following inactivation by S-thiomethylation is
active and has only a single reactive thiol per dimer (32). These
authors suggested that the slower reacting Cys-282 pair of the dimer is
required for activity with the faster reacting Cys-282 thiol, providing
protection. The essential role of Cys-282 in catalysis has been
the source of much investigation. Recent mutagenesis studies have shown
that Cys-282 may play a role in substrate binding by maintaining the
conformation of the active site but is not essential for catalysis
(33). The recent crystal structure of rabbit muscle creatine kinase has
shown that Cys-282 is close to the active site region of the enzyme
(17).
A faster running form of creatine kinase monomer has been identified
using denaturing polyacrylamide gel electrophoresis and was postulated
as an oxidized non-reducible form of the enzyme that did not involve
the essential Cys-282 (34). The formation of internal disulfides in
proteins is sufficient to induce conformational changes producing
detectable alterations in mobility on denaturing polyacrylamide gels
(35). Our results provide evidence for a subtle relationship between
the oxidized and reduced forms of the monomers of creatine kinase and
enzymic activity. Formation of up to 50% of the 37-kDa form when
assessed by a 1:1 distribution on polyacrylamide gel electrophoresis
leaves the activity unchanged. This is consistent with the proposal
(32) that only a single active thiol is required per dimer if in our
results only one of the two monomers of the dimer is oxidized (Scheme
1). The crystal structure of creatine kinase (17) shows that an
internal disulfide can only be formed between Cys-282 and Cys-73. These
residues are about 7 Å apart, and thus some movement in the region
containing Cys-282 would be required to bring them close enough for
reaction.2 This
movement may be induced by covalent binding of gliotoxin to Cys-282.
Reformation of the 42-kDa species by dithiothreitol is consistent with
formation of such an internal disulfide. Further oxidation of the
second monomer would account for subsequent loss of activity because
the essential Cys-282 would now be internally modified in both
monomers. Dithiothreitol releases free Cys-282 in both monomers and
restores activity. Initial binding to Cys-282 forming a covalently
bound complex as shown in Scheme 2 is
supported by our observation that peptides, albeit generally in minor
amounts, corresponding to Cys-282 can be isolated from digests of
modified creatine kinase. This activates Cys-282 to internal disulfide formation by Cys-73 with the subsequent loss of bound gliotoxin, a
mechanism formally similar to reduction of disulfide bonds by glutathione (36). This proposal is consistent with very little gliotoxin covalently associated with creatine kinase at 5 min even
though half of the monomers have been converted to the 37-kDa form with
no loss in activity. Monomer cross-linking does not occur because an
84-kDa species is not detected. The slower conversion of the second
monomer to the 37-kDa form results in loss of all activity, enzyme
denaturation, and modification of Cys-253 consistent with a single
gliotoxin molecule associated with the oxidized form at 3 and 4.5 h. The increased binding to the minor 42-kDa form at 4.5 h may
reflect further binding of gliotoxin to free thiol groups although
labeled peptides corresponding to other residues were not detected.
When gliotoxin forms a mixed disulfide, the second thiol of the toxin
is exposed (Scheme 2). Thus it may be possible for this thiol to react
with a second gliotoxin resulting in an increase in associated label.
The inactivation profile in Fig. 5 clearly supports our proposal that
conversion to the 37-kDa form results in inactivation only when
the second monomer of the dimer is so affected.
We have identified a novel route to inactivation of rabbit muscle
creatine kinase by the fungal toxin gliotoxin involving formation of an
internal disulfide bond probably between the essential Cys-282 and
Cys-73. This is the first direct evidence of the protective effect
ascribed to modification of one monomer of the creatine kinase dimer
via Cys-282 against a redox-active toxin.
Gliotoxin has been shown to induce apoptosis in cells, and one possible
cellular target for gliotoxin may be the mitochondria that play an
essential role in apoptotic death (37). It is significant that
gliotoxin has been shown to release calcium from isolated mitochondria
by modification of as yet unidentified neighboring thiol groups (38,
39). Mitochondrial creatine kinase may be a component of the
multiprotein mitochondrial pore (14), and the possibility that
gliotoxin is interacting with these organelles via creatine kinase is
under investigation. Gliotoxin and its analogs can also induce
intracellular calcium fluxes (40) possibly by allowing direct entry of
calcium through the plasma
membrane.3 Inhibition of
creatine kinase that is associated with plasma membrane
ATP-dependent calcium pumps would disable this route of
calcium extrusion and allow uncontrolled calcium increases.
We thank Dr. Gareth Chelvanayagam for very
helpful advice and T. Davies for excellent technical assistance.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Division of
Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Mills Rd., Acton, Canberra, ACT, Australia 2601. Tel.: 026-249-2595; Fax: 026-249-2595; E-mail: Paul.Waring@anu.edu.au.
Published, JBC Papers in Press, May 25, 2000, DOI 10.1074/jbc.M002278200
3
A. M. Hurne, C. L. L. Chai, and P. Waring, manuscript in preparation.
2
G. Chelvanayagam, personal communication.
The abbreviation used is:
ETP, epipolythiodioxopiperazine.
Inactivation of Rabbit Muscle Creatine Kinase by Reversible
Formation of an Internal Disulfide Bond Induced by the Fungal Toxin
Gliotoxin*
,
¶
Division of Immunology and Cell Biology,
John Curtin School of Medical Research and the § Department
of Chemistry, The Faculties, Australian National University, Canberra,
Australian Capital Territory, Australia 2601
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
Materials and Methods
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
Materials and Methods
RESULTS
DISCUSSION
REFERENCES
B (10).
![]()
Materials and Methods
TOP
ABSTRACT
INTRODUCTION
Materials and Methods
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
Materials and Methods
RESULTS
DISCUSSION
REFERENCES

View larger version (16K):
[in a new window]
Fig. 1.
Time-dependent inactivation of
creatine kinase (CK) by 100 µM gliotoxin. A time lag
of almost 90 min occurs before any significant inactivation. The
reaction occurs at a concentration of creatine kinase of 25 µM (monomer) at pH 9.0, 37 0C.
,
untreated creatine kinase;
, creatine kinase treated with 100 µM gliotoxin.

View larger version (59K):
[in a new window]
Fig. 2.
A, native creatine kinase showing the
presence of a small amount of the 37-kDa oxidized form (lane
1). Lane 2, native creatine kinase was treated with 500 µM dithiothreitol for 60 min. B, native
creatine kinase following treatment with 500 µM
dithiothreitol and exhaustive dialysis (lane 1). Lane
2, the same sample of creatine kinase treated with 500 µM dithiothreitol and kept on ice. The concentration of
creatine kinase is 25 µM (monomer). Values in parentheses
are the relative activities (as determined under "Materials and
Methods") of the two samples normalized with the undialyzed sample.
Volume changes during dialysis were estimated at lower than 5%.

View larger version (30K):
[in a new window]
Fig. 3.
Effect of 100 µM gliotoxin on the formation
of oxidized creatine kinase (CK). Top,
lanes 1, 3, 5, and 7 show control
enzyme at 5 min, 1 h, 3 h, and 6 h, respectively.
Lanes 2, 4, 6, and 8 show
treated enzyme at 5 min, 1 h, 3 h, and 6 h,
respectively. The reaction conditions consisted of a
concentration of creatine kinase of 25 µM (monomer) at pH
9.0. Bottom, % conversion to 37-kDa form with time.
,
treated with toxin;
, control.

View larger version (31K):
[in a new window]
Fig. 4.
Conversion of gliotoxin-treated
creatine kinase from the oxidized to the reduced form with
dithiothreitol. Lane 1, creatine kinase was treated with 100 µM gliotoxin for 6 h; lane 2, creatine
kinase was treated with 10 µM gliotoxin for 6 h;
lane 3, untreated creatine kinase; lane 4,
untreated creatine kinase and 1 mM dithiothreitol for 60 min; lane 5, creatine kinase was treated with 10 µM gliotoxin for 6 h and 1 mM
dithiothreitol for 60 min; lane 6, creatine kinase was
treated with 100 µM gliotoxin for 6 h and 1 mM dithiothreitol for 60 min.
50% of the oxidized 37-kDa form were ignored, and a best fit line was
constructed. Similarly, all points which corresponded
to
50% of the oxidized form were then ignored to generate a
second line of best fit.

View larger version (17K):
[in a new window]
Fig. 5.
The relationship between creatine kinase
(CK) activity and the relative proportion of the
oxidized (37-kDa) form. Data are taken from a number of
experiments in which both the activity and the proportion of the
oxidized form were assessed in the same experiment. The dotted
line is the theoretical result for the model of inactivation
presented in the text and in Scheme 1.

View larger version (13K):
[in a new window]
Scheme 1.
The three possible compositions of the
dimer of creatine kinase formed by internal disulfide bond formation
between Cys-73 and Cys-282. R, reduced; O,
oxidized.
The Stoichiometry of gliotoxin bound to creatine kinase
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
Materials and Methods
RESULTS
DISCUSSION
REFERENCES

View larger version (8K):
[in a new window]
Scheme 2.
Proposed mechanism for formation of an
internal disulfide bond in creatine kinase (CK) that
is catalyzed by gliotoxin. The initial intermediate mixed
disulfide (A) formed by covalent interaction of gliotoxin
with Cys-282 undergoes a unimolecular reaction with an adjacent thiol
and the formation of the oxidized enzyme (B). Radiolabel is
lost during this process.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
Materials and Methods
RESULTS
DISCUSSION
REFERENCES
1.
Waring, P.,
Eichner, R. D.,
and Mullbacher, A.
(1988)
Med. Res. Rev.
8,
499-524
2.
Mullbacher, A.,
Waring, P.,
Tiwari-Palni, U.,
and Eichner, R. D.
(1986)
Mol. Immunol.
23,
231-235
3.
Waring, P.,
Newcombe, N. R.,
Edel, M.,
Lin, Q. H.,
Jiang, H.,
Sjaarda, A.,
Piva, T.,
and Mullbacher, A.
(1988)
Toxicon
32,
491-504
4.
Bodey, G.,
Bueltmann, B.,
Duguid, W.,
Gibbs, D.,
Hanak, H.,
Naoe, S.,
Okudaira, M.,
Scevola, D.,
and van't Wout, J.
(1992)
Eur. J. Clin. Microbiol. Infect. Dis.
11,
99-109
5.
Sutton, P.,
Newcombe, N. R.,
Waring, P.,
and Mullbacher, A.
(1994)
Infect. Immun.
62,
1192-1198
6.
Waring, P.,
Khan, T.,
and Sjaarda, A.
(1997)
J. Biol. Chem.
272,
17929-17936
7.
Waring, P.,
Sjaarda, A.,
and Lin, Q. H.
(1995)
Biochem. Pharmacol.
49,
1195-1201
8.
De Clercq, E.,
Billiau, A.,
Ottenheijm, H. C. J.,
and Herscheid, J. D. M.
(1978)
Biochem. Pharmacol.
27,
635-639
9.
Hara, H. A. H.,
and Han, M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
3333-3337
10.
Pahl, H. L.,
Kraub, B.,
Schulze-Osthoff, K.,
Decker, T.,
Traencker, E. B. M,
Myers, C.,
Parks, T.,
Waring, P.,
Czernilofsky, A. P.,
and Baeuerle, P.
(1996)
J. Exp. Med.
183,
1829-1840
11.
Watts, D. C.
(1973)
in
The Enzymes
(Boyer, P. D., ed), Vol. 8
, pp. 384-451, Academic Press, NY
12.
Walliman, T.,
Schlosser, T.,
and Eppenberger, H. M.
(1984)
J. Biol. Chem.
259,
5238-5246
13.
Rossi, A. M.,
Eppenberger, H. M.,
Volpe, P.,
Cotrufo, R.,
and Walliman, T.
(1990)
J. Biol. Chem.
265,
5258-5266
14.
Beutner, G.,
Ruck, A.,
Riede, B.,
and Brdiczka, D.
(1998)
Biochim. Biophys. Acta
1368,
7-18
15.
Lillie, J. W.,
O'Keefe, M.,
Valinski, H.,
Hamlin, H. A.,
Varban, M. L.,
and Kaddurah-Daouk, R.
(1993)
Cancer Res.
53,
3172-3178
16.
Walliman, T.,
Wyss, M.,
Brdiczka, D.,
Nicolay, K.,
and Eppenberger, H. M.
(1992)
Biochem. J.
281,
21-40
17.
Rao, J. K. M.,
Bujacz, G.,
and Wlodawer, A.
(1998)
FEBS Lett.
439,
133-137
18.
Tanzer, M. L.,
and Gilvarg, C.
(1959)
J. Biol. Chem.
234,
3201-3204
19.
Yao, Q. Z.,
Tian, M.,
and Tsou, C. L.
(1984)
Biochemistry
23,
2740-2744
20.
Laemmli, U. K.
(1970)
Nature
277,
680-685
21.
Munday, R.
(1987)
J. Appl. Toxicol.
7,
17-22
22.
Buechter, D. D.,
Medzihradszky, K. F.,
Burlingame, A. L.,
and Kenyon, G. L.
(1992)
J. Biol. Chem.
267,
2173-2178
23.
Clottes, E.,
Couthon, F.,
Denoroy, L.,
and Vial, C.
(1994)
Biochim. Biophys. Acta
1209,
171-176
24.
Tanaka, N.,
Tonai, T.,
and Kunugi, S.
(1997)
Biochim. Biophys. Acta
1339,
226-232
25.
Dawson, D. M.,
Eppenberger, H. M.,
and Kaplan, N. O.
(1965)
Biochem. Biophys. Res. Commun.
21,
346-353
26.
Degani, Y.,
and Degani, C.
(1979)
Biochemistry
18,
5917-5923
27.
Wang, X-C.,
Zhou, H-M.,
Wang, Z-X.,
and Tsou, C-L.
(1990)
Biochim. Biophys. Acta
1039,
313-317
28.
Grossman, S. H.,
Gray, K. A.,
and Lense, J. J.
(1986)
Arch. Biochem. Biophys.
248,
234-242
29.
Price, N. C.,
and Hunter, M. G.
(1976)
Biochim. Biophys. Acta
445,
364-376
30.
Wang, Z-X.,
Preiss, B.,
and Tsou, C-L.
(1988)
Biochemistry
27,
5095-5100
31.
Hou, L-X.,
and Vollmer, S.
(1994)
Biochim. Biophys. Acta
1205,
83-88
32.
Hou, L-X.,
and Zhou, J-X.
(1996)
Biochimie (Paris)
78,
219-226
33.
Furter, R.,
Furter-Graves, E. M.,
and Wallimann, T.
(1993)
Biochemistry
32,
7022-7029
34.
Wang, X-C.,
Wang, F.,
Zou, X. M.,
and Zhou, H. M.
(1994)
Sci. China Ser. B
37,
964-974
35.
Hames, B. D. in Gel Electrophoresis of Proteins, A Practical
Approach (Hames, B. D., and Rickwood, D., eds) pp. 1-139,
Oxford University Press, Oxford, United Kingdom
36.
Szajewski, R. P.,
and Whitesides, G. M.
(1980)
J. Am. Chem. Soc.
102,
2011-2026
37.
Green, D. R.,
and Reed, J. C.
(1998)
Science
281,
1309-1312
38.
Schweizer, M.,
and Richter, C.
(1994)
Biochemistry
33,
13401-13405
39.
Silva, J. P.,
Winterhalter, K. H.,
and Richter, C.
(1997)
Redox Report
3,
331-341
40.
Beaver, J. P.,
and Waring, P.
(1994)
Immunol. Cell Biol.
72,
489-499
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. M. Gardiner, P. Waring, and B. J. Howlett The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis Microbiology, April 1, 2005; 151(4): 1021 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stanzani, E. Orciuolo, R. Lewis, D. P. Kontoyiannis, S. L. R. Martins, L. S. St. John, and K. V. Komanduri Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes Blood, March 15, 2005; 105(6): 2258 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nishida, L. S. Yoshida, T. Shimoyama, H. Nunoi, T. Kobayashi, and S. Tsunawaki Fungal Metabolite Gliotoxin Targets Flavocytochrome b558 in the Activation of the Human Neutrophil NADPH Oxidase Infect. Immun., January 1, 2005; 73(1): 235 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Bernardo, N. Brasch, C. L. L. Chai, and P. Waring A Novel Redox Mechanism for the Glutathione-dependent Reversible Uptake of a Fungal Toxin in Cells J. Biol. Chem., November 21, 2003; 278(47): 46549 - 46555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hurne, C. L. L. Chai, K. Moerman, and P. Waring Influx of Calcium through a Redox-sensitive Plasma Membrane Channel in Thymocytes Causes Early Necrotic Cell Death Induced by the Epipolythiodioxopiperazine Toxins J. Biol. Chem., August 23, 2002; 277(35): 31631 - 31638. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |